Loading
Latest filing published 15 Mar 2021 for Tetra Bio-Pharma Inc., €33k.
No signal scores available.
Dale Weil discloses dealings in Tetra Bio-Pharma Inc. to SEDI. The record holds 2 filings, for trades running from 14 September 2020 to 10 March 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 March 2021, the filings show a share grant worth €33k in Tetra Bio-Pharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.